Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Acrivon Therapeutics, Inc. (ACRV)  
$8.77 0.63 (7.74%) as of 4:30 Fri 5/10


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 20,880,000
Market Cap: 183.12(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $3.4 - $14.09
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    : 20.1
Insider 6 Months    : 20.1
Insider 3/6 Months : 40.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 2,353,000 2,353,000 2,353,000 6,142,500
Total Buy Value $20,000,500 $20,000,500 $20,000,500 $67,369,250
Total People Bought 1 1 1 3
Total Buy Transactions 1 1 1 3
Total Shares Sold 0 0 5,909 5,909
Total Sell Value $0 $0 $72,619 $72,619
Total People Sold 0 0 1 1
Total Sell Transactions 0 0 4 4
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 43
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Shah Rajeev M. Director   –       •       •   2022-11-17 4 A $0.00 $0 I/I 1,421,008 426,302     -
   Shah Rajeev M. Director   –       •       •   2022-11-17 4 B $12.50 $42,368,750 I/I 3,389,500 4,384,206 2.25 -19%     
   Wellington Biomedical Innovation Master Investors   –       –       •   2022-11-17 4 A $0.00 $0 D/D 888,130 888,130     -
   Smolokowski Wiaczeslaw 10% Owner   –       –       •   2022-11-17 4 A $0.00 $0 D/D 3,456,597 3,856,597     -
   Smolokowski Wiaczeslaw 10% Owner   –       –       •   2022-11-17 4 B $12.50 $5,000,000 D/D 400,000 3,856,597 2.45 -19%     
   Edelman Joseph 10% Owner   –       –       •   2022-11-17 3 IO $0.00 $0 I/I 0 3,007,858 -19%     
   Blume-Jensen Peter President and CEO   •       •      –    2022-11-14 4 A $0.00 $0 I/I 26,707 320,705     -
   Blume-Jensen Peter President and CEO   •       •      –    2022-11-14 4 A $0.00 $0 D/D 1,498,240 2,370,097     -
   Gamelin Erick Chief Medical Officer   •       –      –    2022-11-14 4 A $0.00 $0 D/D 20,030 20,030     -
   Holm-Jorgensen Rasmus Chief Financial Officer   •       –      –    2022-11-14 4 A $0.00 $0 D/D 20,030 20,030     -
   Masson Kristina EVP - Business Operations   •       •      –    2022-11-14 4 A $0.00 $0 I/I 1,498,240 2,370,097     -
   Masson Kristina EVP - Business Operations   •       •      –    2022-11-14 4 A $0.00 $0 D/D 26,707 320,705     -
   Devroe Eric Chief Operating Officer   •       –      –    2022-11-14 4 A $0.00 $0 D/D 33,383 53,658     -
   Blume-Jensen Peter President and CEOOfficer   •       •      –    2022-11-09 3 IO $0.00 $0 I/I 0 293,998     -
   Blume-Jensen Peter President and CEOOfficer   •       •      –    2022-11-09 3 IO $0.00 $0 D/D 0 871,857     -
   Masson Kristina EVP - Business OperationsOffic   •       •      –    2022-11-09 3 IO $0.00 $0 I/I 0 871,857     -
   Masson Kristina EVP - Business OperationsOffic   •       •      –    2022-11-09 3 IO $0.00 $0 D/D 0 293,998     -
   Devroe Eric Chief Operating OfficerOfficer   •       –      –    2022-11-09 3 IO $0.00 $0 D/D 0 20,275     -

  43 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed